Together, these results highlight the role of REPS1 as a key signaling protein impaired in insulin resistance and suggest that enhancing REPS1 phosphorylation could be a potential therapeutic strategy to improve insulin sensitivity and restore glucose uptake in metabolic disorders such as T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.